There is a need to improve personalized immunosuppression in organ transplantation to
reduce premature graft loss. Biomarkers are needed to better detect rejection, asymptomatic …

The use of noninvasive biomarkers may reduce the need for biopsy and guide
immunosuppression adjustments during transplantation. The scientific community in solid …

Maintenance of long-term lung allograft health in lung transplant recipients (LTRs) requires
a fine balancing act between providing sufficient immunosuppression to reduce the risk of …

In kidney transplantation, a biopsy is currently the gold standard for monitoring the
transplanted organ. However, this is far from an ideal screening method given its invasive …

Transplant patients often suffer graft rejection. Chronic allograft dysfunction can result from
multiple both immunologic and nonimmunologic causes. Immunologic causes include acute …

Lung transplant recipients have experienced an improvement in survival over the last
decade due to advancements in donor procurement, surgical techniques, and medical …

Background Circulating donor-derived cell-free DNA (dd-cfDNA) levels have been proposed
as a potential tool for the diagnosis of graft injury. In this study, we prospectively investigated …